© 1997 American Heart Association, Inc.
Articles |
Expression of Inducible Nitric Oxide Synthase in Rat Experimental Autoimmune Myocarditis With Special Reference to Changes in Cardiac Hemodynamics
the Department of Pharmacology (S.H., M.O.I., M.N., Y.Y., S.I.) and the First Department of Internal Medicine (M.K., A.S.), Niigata (Japan) University School of Medicine, and the Department of Internal Medicine (T.I.), Kitasato University School of Medicine, Sagamihara, Japan.
Correspondence to Shoichi Imai, MD, Department of Pharmacology, Niigata University School of Medicine, Asahimachi 1-757, Niigata 951, Japan. E-mail shimai@med.niigata-u.ac.jp
Excessive NO produced by an inducible NO synthase (iNOS) has been implicated in many types of immune-associated disorders of the cardiovascular system, but it remains to be determined whether NO plays a role in myocarditis. Thus, the significance of iNOS expression in the development of experimental autoimmune myocarditis (EAM), an animal model of human giant cell myocarditis, was investigated. Lewis rats were immunized with cardiac myosin and were killed 7, 14, 21, 28, and 49 days after immunization. The development of severe myocarditis was observed on days 14, 21, and 28 in association with significant deterioration of hemodynamics determined by cardiac catheterization, which peaked on day 21. In parallel with histological severity of myocarditis and deterioration of cardiac performance, iNOS activity in the heart measured by [14C]L-citrulline formation was markedly increased on days 14, 21, and 28. The expression of iNOS was confirmed by immunoblotting and was localized to the infiltrating inflammatory cells found in the vicinity of necrotic myocytes by immunohistochemical analysis. Aminoguanidine, a selective inhibitor of iNOS, significantly decreased the iNOS activity (1.04±0.37 compared with 29.1±8.62 pmol·min-1·mg protein-1 in untreated myosin-immunized rats, P<.01) and effectively attenuated histopathological changes of EAM on day 21. Hemodynamic parameters were also improved from 64±3 to 89±3 mm Hg for mean blood pressure, from 80±2 to 113±4 mm Hg for left ventricular systolic pressure, from 7.8±0.3 to 3.2±0.3 mm Hg for left ventricular end-diastolic pressure, from 2867±137 to 4180±102 mm Hg/s for +dP/dt, and from 2717±132 to 4180±184 mm Hg/s for -dP/dt (P<.01). The values after aminoguanidine treatment were not significantly different from the control values. These results suggest an important role for NO in mediating pathophysiological changes in myocarditis of autoimmune origin.
Key Words: myocarditis • cardiomyopathy • nitric oxide synthase • hemodynamics • aminoguanidine
This article has been cited by other articles:
 |
|
 |
|
  T. Horii, K. Tambara, K. Nishimura, H. Suma, and M. Komeda Residual fibrosis affects a long-term result of left ventricular volume reduction surgery for dilated cardiomyopathy in a rat experimental study Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1174 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Herrmann, A. D. McCulloch, and J. H. Omens Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1277 - H1284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kawada, M. Nakazawa, S. Nakauchi, K. Yamazaki, R. Shimamoto, M. Urabe, J. Nakata, C. Hemmi, F. Masui, T. Nakajima, et al. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: Amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters PNAS, January 22, 2002; 99(2): 901 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Abe, M. Tokumura, T. Ito, T. Murai, A. Takashima, and N. Ibii Involvement of iNOS in postischemic heart dysfunction of stroke-prone spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H668 - H673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M T Kearney, J M Cotton, P J Richardson, and A M Shah Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management Postgrad. Med. J., January 1, 2001; 77(903): 4 - 10. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Ito, M. Kodama, M. Masuko, M. Yamaura, K. Fuse, Y. Uesugi, S. Hirono, Y. Okura, K. Kato, Y. Hotta, et al. Expression of Coxsackievirus and Adenovirus Receptor in Hearts of Rats With Experimental Autoimmune Myocarditis Circ. Res., February 18, 2000; 86(3): 275 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M Shah Inducible nitric oxide synthase and cardiovascular disease Cardiovasc Res, January 1, 2000; 45(1): 148 - 155. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Arstall, D. B. Sawyer, R. Fukazawa, and R. A. Kelly Cytokine-Mediated Apoptosis in Cardiac Myocytes : The Role of Inducible Nitric Oxide Synthase Induction and Peroxynitrite Generation Circ. Res., October 29, 1999; 85(9): 829 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury Cardiovasc Res, August 15, 1999; 43(3): 698 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hanawa, T. Inomata, Y. Okura, S. Hirono, Y. Ogawa, T. Izumi, M. Kodama, and Y. Aizawa T Cells With Similar T-Cell Receptor ß-Chain Complementarity-Determining Region 3 Motifs Infiltrate Inflammatory Lesions of Synthetic Peptides Inducing Rat Autoimmune Myocarditis Circ. Res., July 27, 1998; 83(2): 133 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hasenfuss Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res, July 1, 1998; 39(1): 60 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Paulus, S. Kastner, P. Pujadas, A. M. Shah, H. Drexler, and M. Vanderheyden Left Ventricular Contractile Effects of Inducible Nitric Oxide Synthase in the Human Allograft Circulation, November 18, 1997; 96(10): 3436 - 3442. [Abstract] [Full Text]
|
|
|
|
|
|
S. Mikami, S. Kawashima, K. Kanazawa, K.-i. Hirata, H. Hotta, Y. Hayashi, H. Itoh, and M. Yokoyama Low-Dose N{omega}-Nitro-L-Arginine Methyl Ester Treatment Improves Survival Rate and Decreases Myocardial Injury in a Murine Model of Viral Myocarditis Induced by Coxsackievirus B3 Circ. Res., October 19, 1997; 81(4): 504 - 511. [Abstract] [Full Text]
|
|
|
|
|
|
R. A. Kelly and T. W. Smith Cytokines and Cardiac Contractile Function Circulation, February 18, 1997; 95(4): 778 - 781. [Full Text]
|
|